BIOGEN INC. Deferred Tax Liabilities, Inventory
BIOGEN INC. (BIIB) had Deferred Tax Liabilities, Inventory of $1.10 million as of 2014-12-31, per its 10-K filed 2015-02-04.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Liabilities, Gross
us-gaap:DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts · last filed 2015-02-04
- 2014-12-31: Deferred Tax Liabilities, Inventory $1.10M.
- 2013-12-31: Deferred Tax Liabilities, Inventory $24.90M.
- 2012-12-31: Deferred Tax Liabilities, Inventory $50.80M.
- 2011-12-31: Deferred Tax Liabilities, Inventory $76.80M; Deferred Tax Liabilities, Inventory as first filed -$76.80M.
| Period end | Deferred Tax Liabilities, Inventory | Deferred Tax Liabilities, Inventory as first filed |
|---|---|---|
| 2014-12-31 | $1.10M 10-K · filed 2015-02-04 | |
| 2013-12-31 | $24.90M 10-K · filed 2015-02-04 | |
| 2012-12-31 | $50.80M 10-K · filed 2014-02-06 | |
| 2011-12-31 | $76.80M 10-K · filed 2013-02-05 | -$76.80M 10-K · filed 2012-02-03 |
| 2010-12-31 | $0.00 10-K · filed 2012-02-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |